Therefore, the upregulated SOX9 might contribute to the ISO-mediated attenuation of kidney injuries and preservation of renal functions, and YAP1 might be involved in the ISO-mediated modulation of the SOX9 expression, but more experimental results were required for uncovering the molecular traits of the pharmacological effects of ISO. The gene discussed is SOX9; the disease is urogenital neoplasm.